#392 – Genetic Testing: When It’s Valuable, How to Choose the Right Test, and What to Do with the Results

Key Takeaways

• Genetic tests excel for high‑penetrance mutations like BRCA, APOE
• Phenotype data often outperforms DNA for routine risk assessment
• Actionable results must influence screening or treatment decisions
• Consumer‑direct tests are cheap but frequently lack clinical relevance

Pulse Analysis

The rapid drop in sequencing costs has turned genetic testing from a research curiosity into a consumer product. Companies now market everything from diet plans to supplement regimens based on a handful of SNPs, capitalizing on the public’s fascination with a "personalized" health blueprint. While the technology is impressive—whole‑genome sequencing can be performed for under $200—the flood of data often outpaces clinicians’ ability to interpret it, leading to confusion and over‑interpretation.

Clinically, genetic testing shines when it identifies high‑penetrance variants that dramatically alter disease risk or treatment pathways. For example, detecting a pathogenic BRCA1/2 mutation can trigger earlier mammography, prophylactic surgery, and cascade testing for relatives. Similarly, APOE‑ε4 status informs Alzheimer’s risk counseling, and pharmacogenomic panels can guide statin or anticoagulant choices. However, for most common conditions—type 2 diabetes, hypertension, or general cardiovascular risk—environmental factors and measurable phenotypes (blood pressure, lipid panels, imaging) provide clearer, actionable information than a modest increase in polygenic risk scores.

Patients should approach genetic testing with a decision framework: define the precise clinical question, verify that a validated test exists, and confirm that a positive result would change management. Without an actionable pathway, the test adds cost without benefit and may generate anxiety. As the field matures, integration of genomic data into electronic health records and evidence‑based guidelines will help clinicians filter signal from noise, ensuring that DNA testing complements, rather than replaces, traditional diagnostic tools.